Business Context and Reporting Period
This Form 6-K filing is submitted by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in metadata) for the month of July 2019. The registrant is a foreign private issuer headquartered in Abingdon, Oxfordshire, United Kingdom. The filing serves to disclose a corporate governance update rather than financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change disclosed in this filing is the appointment of a Non-Executive Director, as detailed in the attached press release dated July 31, 2019. No financial material changes are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is limited to the formal notification of the director appointment.
Key Facts for Investor Verification
- Verify the identity and background of the newly appointed Non-Executive Director referenced in Exhibit 99.1.
- Confirm that the registrant name is Midatech Pharma PLC, noting the discrepancy with the "Biodexa Pharmaceuticals Plc" label in the request metadata.
- Check subsequent filings for the next scheduled financial report, as this 6-K contains no financial data.